Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Perspective

Perspectives of Plasma-treated Solutions as Anticancer Drugs

Author(s): Pankaj Attri* and Annemie Bogaerts

Volume 19, Issue 4, 2019

Page: [436 - 438] Pages: 3

DOI: 10.2174/187152061904190521102345

[1]
International Agency for Research on Cancer, GLOBOCAN 2018 accessed via Global Cancer Observatory. Accessed September. 2018.
[2]
Yan, D.; Sherman, J.H.; Keidar, M. The application of the cold atmospheric plasma-activated solutions in cancer treatment. Anticancer. Agents Med. Chem., 2018, 18(6), 769-775.
[3]
Gjika, E.; Pal-Ghosh, S.; Tang, A.; Kirschner, M.; Tadvalkar, G.; Canady, J.; Stepp, M.A.; Keidar, M. Adaptation of operational parameters of cold atmospheric plasma for in vitro treatment of cancer cells. ACS Appl. Mater. Interfaces, 2018, 10(11), 9269-9279.
[4]
Ikeda, J-I.; Tsuruta, Y.; Nojima, S.; Sakakita, H.; Hori, M.; Ikehara, Y. Anti-Cancer effects of nonequilibrium atmospheric pressure plasma on cancer-initiating cells in human endometrioid adenocarcinoma cells. Plasma Process. Polym., 2015, 12(12), 1370-1376.
[5]
Privat-Maldonado, A.; Gorbanev, Y.; Dewilde, S.; Smits, E.; Bogaerts, A.; Privat-Maldonado, A.; Gorbanev, Y.; Dewilde, S.; Smits, E.; Bogaerts, A. Reduction of human glioblastoma spheroids using cold atmospheric plasma: The combined effect of short- and long-lived reactive species. Cancers (Basel), 2018, 10(11), 394.
[6]
Tanaka, H.; Mizuno, M.; Ishikawa, K.; Nakamura, K.; Kajiyama, H.; Kano, H.; Kikkawa, F.; Hori, M. Plasma-activated medium selectively kills glioblastoma brain tumor cells by down-regulating a survival signaling molecule, AKT kinase. Plasma Med., 2011, 1(3-4), 265-277.
[7]
Sato, Y.; Yamada, S.; Takeda, S.; Hattori, N.; Nakamura, K.; Tanaka, H.; Mizuno, M.; Hori, M.; Kodera, Y. Effect of plasma-activated lactated Ringer’s solution on pancreatic cancer cells in vitro and in vivo. Ann. Surg. Oncol., 2018, 25(1), 299-307.
[8]
Matsuzaki, T.; Kano, A.; Kamiya, T.; Hara, H.; Adachi, T. Enhanced ability of plasma-activated lactated Ringer’s solution to induce A549 cell injury. Arch. Biochem. Biophys., 2018, 656, 19-30.
[9]
Bekeschus, S.; Käding, A.; Schröder, T.; Wende, K.; Hackbarth, C.; Liedtke, K.R.; van der Linde, J.; von Woedtke, T.; Heidecke, C-D.; Partecke, L-I. Cold physical plasma-treated buffered saline solution as effective agent against pancreatic cancer cells. Anticancer. Agents Med. Chem., 2018, 18(6), 824-831.
[10]
Kumar, N.; Attri, P.; Dewilde, S.; Bogaerts, A. Inactivation of human pancreatic ductal adenocarcinoma with atmospheric plasma treated media and water: A comparative study. J. Phys. D Appl. Phys., 2018, 51(25), 255401.
[11]
Chauvin, J.; Judee, F.; Merbahi, N.; Vicendo, P. Effects of plasma activated medium on head and neck FaDu cancerous cells: Comparison of 3D and 2D response. Anticancer. Agents Med. Chem., 2018, 18(6), 776-783.
[12]
Saadati, F.; Mahdikia, H.; Abbaszadeh, H-A.; Abdollahifar, M-A.; Khoramgah, M.S.; Shokri, B. Comparison of direct and indirect cold atmospheric-pressure plasma methods in the B16F10 melanoma cancer cells treatment. Sci. Rep., 2018, 8(1), 7689.
[13]
Ikeda, J.; Tanaka, H.; Ishikawa, K.; Sakakita, H.; Ikehara, Y.; Hori, M. Plasma-Activated Medium (PAM) kills human cancer-initiating cells. Pathol. Int., 2018, 68(1), 23-30.
[14]
Boehm, D.; Curtin, J.; Cullen, P.J.; Bourke, P. Hydrogen peroxide and beyond-the potential of high-voltage plasma-activated liquids against cancerous cells. Anticancer. Agents Med. Chem., 2018, 18(6), 815-823.
[15]
Van Boxem, W.; Van der Paal, J.; Gorbanev, Y.; Vanuytsel, S.; Smits, E.; Dewilde, S.; Bogaerts, A. Anti-cancer capacity of plasma-treated PBS: Effect of chemical composition on cancer cell cytotoxicity. Sci. Rep., 2017, 7(1), 16478.
[16]
Attri, P.; Park, J.H.; Ali, A.; Choi, E.H. How does plasma activated media treatment differ from direct cold plasma treatment? Anticancer. Agents Med. Chem., 2018, 18(6), 805-814.
[17]
Bauer, G. Targeting protective catalase of tumor cells with cold atmospheric Plasma- Activated Medium (PAM). Anticancer. Agents Med. Chem., 2018, 18(6), 784-804.
[18]
Adachi, T.; Nonomura, S.; Horiba, M.; Hirayama, T.; Kamiya, T.; Nagasawa, H.; Hara, H. Iron stimulates plasma-activated medium-induced A549 cell injury. Sci. Rep., 2016, 6(1), 20928.
[19]
Kumar, N.; Park, J.H.; Jeon, S.N.; Park, B.S.; Choi, E.H.; Attri, P. The action of microsecond-pulsed plasma-activated media on the inactivation of human lung cancer cells. J. Phys. D Appl. Phys., 2016, 49(11), 115401.
[20]
Utsumi, F.; Kajiyama, H.; Nakamura, K.; Tanaka, H.; Mizuno, M.; Ishikawa, K.; Kondo, H.; Kano, H.; Hori, M.; Kikkawa, F. Effect of indirect nonequilibrium atmospheric pressure plasma on anti-proliferative activity against chronic chemo-resistant ovarian cancer cells in vitro and in vivo. PLoS One, 2013, 8(12), e81576.

© 2024 Bentham Science Publishers | Privacy Policy